This file is part of IDEAS , which uses RePEc data
[ Papers |
Articles |
Software |
Books |
Chapters |
Authors |
Institutions |
JEL Classification |
NEP reports |
Search |
New papers by email |
Author registration |
Rankings |
Volunteers |
FAQ |
Blog |
Help! ]
A primer on the economics of re-importation of prescription drugs Author info | Abstract | Publisher info | Download info | Related research | Statistics Ernst R. Berndt
Using the basic tools of intermediate microeconomic theory (such as taught at the level of undergraduate or first-year MBA courses), in this primer I present a framework that helps the reader gain an understanding of economic issues underlying the current political economy debates concerning the impacts on consumers (both US and ex-US) and on prescription pharmaceutical manufacturers of moving to a world with more uniform pricing across countries than is currently the case. The impact on global revenues and profitability of moving from differential to uniform global pricing is relatively modest if confined to the North American (US and Canadian) market, with only Canadians bearing the brunt of higher prices, a most unlikely political economy outcome. The impacts on global revenues and profitability from global uniform prices become considerably larger, however, when one incorporates the much larger entire ex-US market, including not only Canada, but also Europe, Asia and other countries. I conclude with some observations on likely longer term outcomes. Copyright © 2007 John Wiley & Sons, Ltd.
To download:
If you experience problems downloading a file, check if you have the
proper application to
view it first. Information about this may be contained
in the File-Format links below. In case of further problems read
the IDEAS help
page . Note that these files are not on the IDEAS
site. Please be patient as the files may be large.
Article provided by John Wiley & Sons, Ltd. in its journal Managerial and Decision Economics .
Volume (Year): 28 (2007)
Issue (Month): 4-5 ()
Pages: 415-435
Download reference. The following formats are available: HTML
(with abstract ),
plain text
(with abstract ),
BibTeX ,
RIS (EndNote, RefMan, ProCite),
ReDIF
Handle: RePEc:wly:mgtdec:v:28:y:2007:i:4-5:p:415-435Contact details of provider: Web page: http://www3.interscience.wiley.com/cgi-bin/jhome/7976
For technical questions regarding this item, or to correct its listing, contact: (Christopher F. Baum).
Keywords: Other versions of this item:
References listed on IDEAS Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile , click on "citations" and make appropriate adjustments.: Joseph Golec & Shantaram Hegde & John A. Vernon, 2005.
"Pharmaceutical Stock Price Reactions to Price Constraint Threats and Firm-Level R&D Spending ,"
NBER Working Papers
11229, National Bureau of Economic Research, Inc.
[Downloadable!] (restricted)
Goldberg, Pinelopi Koujianou & Verboven, Frank, 2001.
"The Evolution of Price Dispersion in the European Car Market ,"
Review of Economic Studies ,
Blackwell Publishing, vol. 68(4), pages 811-48, October.
Other versions: Daron Acemoglu & Joshua Linn, 2004.
"Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry ,"
Levine's Working Paper Archive
228400000000000002, David K. Levine.
[Downloadable!]
Other versions:
Daron Acemoglu & Joshua Linn, 2003.
"Market Size in Innovation: Theory and Evidence From the Pharmaceutical Industry ,"
NBER Working Papers
10038, National Bureau of Economic Research, Inc.
[Downloadable!] (restricted) Daron Acemoglu & Joshua Linn, 2004.
"Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry ,"
The Quarterly Journal of Economics ,
MIT Press, vol. 119(3), pages 1049-1090, August.
[Downloadable!] (restricted) Manning, Richard L, 1997.
"Products Liability and Prescription Drug Prices in Canada and the United States ,"
Journal of Law & Economics ,
University of Chicago Press, vol. 40(1), pages 203-43, April.
Amy Finkelstein, 2004.
"Static and Dynamic Effects of Health Policy: Evidence From the Vaccine Industry ,"
The Quarterly Journal of Economics ,
MIT Press, vol. 119(2), pages 527-564, May.
[Downloadable!] (restricted)
Full
references
Access and
download statistics Did you know? RePEc also has a blog .
This page was last updated on 2009-12-30.
This information is provided to you by IDEAS at the Department of Economics , College of Liberal Arts and Sciences , University of Connecticut using RePEc data on a server sponsored by the Society for Economic Dynamics .